• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Regulatory/Compliance

Dexcom submits 15-day CGM to FDA, beats Street in Q3

October 25, 2024 By Sean Whooley

Dexcom G7 iPhone (1)

Dexcom (Nasdaq:DXCM) announced that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA. G7, the company’s latest-generation continuous glucose monitor (CGM), presently has approval for a 10-day wear time. Shares of DXCM were up slightly at the opening of trading today. Yesterday evening, Dexcom also reported third-quarter results […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Dexcom

FDA approves IDE for Medtronic Prevail drug-coated balloon

October 23, 2024 By Sean Whooley

Medtronic logo updated

Medtronic (NYSE: MDT) announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated balloon (DCB). The medtech giant can now begin a pivotal clinical trial for the coronary paclitaxel DCB for in-stent restenosis (ISR) and de novo small vessel disease. It plans to use data from its Prevail Global Clinical Program […]

Filed Under: Cardiovascular, Drug-Device Combinations, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: FDA, Medtronic

ViCentra wins CE mark for Kaleido insulin pump

October 21, 2024 By Sean Whooley

ViCentra Kaleido Insulin Pump

ViCentra announced that it received CE mark approval for its Kaleido insulin pump under European Medical Device Regulation (EU MDR). Utrecht, The Netherlands-based ViCentra aims to deliver high-quality, user-friendly solutions for people with diabetes. The system last year launched in a hybrid closed-loop automated insulin delivery system that uses the Dexcom G6 CGM. Kaleido features pulse […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance, Technology Tagged With: ViCentra

Medtronic recalls some MiniMed automated insulin delivery systems with battery issues

October 4, 2024 By Sean Whooley

Medtronic MiniMed 780G with Guardian 4 sensor

Medtronic (NYSE:MDT) today announced a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin pumps. FDA deemed the recall Class I, the most serious kind. The medtech giant issued a field action starting on July 31, notifying customers to follow built-in alerts for battery status. Customers should contact Medtronic if […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Technology Tagged With: FDA, Medtronic

Qnovia wins FDA nod for nicotine inhaler as smoking cessation therapy

October 2, 2024 By Sean Whooley

Qnovia nicotine replacement therapy device

Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation inhaler (QN-01). RespiRx, a drug-device combination product, offers inhalable nicotine replacement therapy (NRT) to assist in the quitting of smoking. IND clearance allows Qnovia to initiate a Phase 1 trial in the U.S. to determine the pharmacokinetics, safety, […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, Qnovia

Vivani can begin first-in-human GLP-1 implant trial in Australia following regulatory approval

September 26, 2024 By Sean Whooley

Vivani NanoPortal diabetes implant

Vivani Medical (Nasdaq:VANI) today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 implant. The LIBERATE-1 trial will evaluate the miniature GLP-1 (exenatide) implant in obese and overweight subjects. This follows FDA approval for an investigational new drug (IND) application for the company’s implant in June. The FDA lifted the clinical hold […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Featured, Implants, Regulatory/Compliance Tagged With: Vivani Medical

Tandem wins clearance for t:slim X2 pump with Eli Lilly fast-acting insulin in Europe

September 19, 2024 By Sean Whooley

Tandem Diabetes Care t_slim X2 automated insulin pump Abbott FreeStyle Libre 2 Plus

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its t:slim X2 pump. The company can now offer its automated insulin delivery (AID) system with Eli Lilly’s Lyumjev (insulin lispro-aabc injection) ultra-rapid-acting insulin in Europe. Previously, the t:slim X2 pump had clearance for use with Humalog and […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Regulatory/Compliance, Technology Tagged With: Tandem Diabetes Care

Senseonics wins FDA nod for 365-day implantable CGM

September 17, 2024 By Sean Whooley

Senseonics Eversense 365 Product Image

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system. Eversense 365, an implantable continuous glucose monitor (CGM), becomes the world’s first 365-day CGM system, according to the company. Its indications cover people with type 1 and type 2 diabetes aged 18 years and older. The system also received clearance […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Ascensia Diabetes Care, FDA, Senseonics

Sirtex Medical begins European launch for microsphere delivery system following EU approval

September 16, 2024 By Sean Whooley

Sirtex Siros microsphere delivery system (1)

Sirtex Medical announced today that it received EU MDR certification to market its SIR-Spheres Y-90 resin microspheres and delivery systems. EU MDR authorization enables Woburn, Massachusetts-based Sirtex to kick off a European launch for its Siros delivery system. Siros offers an intuitive, visual and adaptable solution for physicians to administer SIR-Spheres to liver cancer patients. […]

Filed Under: Drug-Device Combinations, Immunotherapy, Oncology, Regulatory/Compliance Tagged With: Sirtex Medical

Smiths Medical warns on infusion cassette reservoirs in Europe

September 4, 2024 By Sean Whooley

Smiths Medical Infusion Medication Cassette Reservoir urgent field safety notice (1)

ICU Medical’s Smiths Medical unit issued an urgent field safety notice in Europe to warn of issues with certain medication cassette reservoirs. Smiths Medical’s warning pertains to specific models and lots of its 50 mL and 100 mL CADD medication cassette reservoirs. Certain reservoirs may exhibit a weakened weld joint between the medication bag and […]

Filed Under: Drug-Device Combinations, Recalls, Regulatory/Compliance Tagged With: ICU Medical, Smiths Medical

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 106
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS